We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for pemigatinib (Specialised Therapeutics Alim Pty Ltd)
Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
tablet
Indication
Treatment of cholangiocarcinoma (CCA)
Therapeutic area
Oncology